Upgrade to SI Premium - Free Trial

Neurocrine Bio. (NBIX) PT Raised to $220 at Oppenheimer on SLNO deal

April 6, 2026 1:59 PM
(Updated - April 6, 2026 1:59 PM EDT)

Oppenheimer analyst Jay Olson raised the price target on Neurocrine Bio ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles